α-thrombin inhibits interleukin-6-induced Stat3 signaling and gp130 gene expression in primary cultures of human lung fibroblasts

被引:8
|
作者
Bhat, GJ [1 ]
Raghu, G [1 ]
Gunaje, JJ [1 ]
Idell, S [1 ]
机构
[1] Univ Texas, Ctr Hlth, Dept Specialty Care Serv, Tyler, TX 75701 USA
关键词
D O I
10.1006/bbrc.1999.0381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exposure of primary human lung fibroblasts (HLF)to interleukin-6 (IL-6) rapidly induced Stat3 (signal transducers and activators of transcription 3) tyrosine phosphorylation. In these cells, alpha-thrombin did not induce tyrosine phosphorylation of Stat3; however, it potently induced its serine phosphorylation. Interestingly, a short pretreatment of cells with alpha-thrombin significantly inhibited IL-6-induced tyrosine phosphorylation of Stat3. The inhibition by alpha-thrombin was attenuated if cells were pretreated:with U0126, a specific inhibitor of the mitogen-activated protein (MAP) kinase kinase 1 (MAPKK1). Exposure of HLF cells to IL-6 induced a twofold increase in gp130 mRNA-levels; however, alpha-thrombin inhibited this IL-6-induced-response almost to control levels. These results demonstrate, for the first time, that in HLF cells alpha-thrombin inhibits IL-6-induced Stat3 signaling via activation of MAPKK1 and that this cross-talk regulates IL-6-induced gp130 gene expression. (C) 1999 Academic Press.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 50 条
  • [1] Interleukin-6-induced STAT3 signaling links inflammation to chronic lung disease in mice
    O'Donoghue, Robert J. J.
    Knight, Darryl A.
    Jarnicki, Andrew G.
    Jones, Jessica
    Anderson, Gary P.
    Mutsaers, Steven E.
    Ernst, Matthias
    CYTOKINE, 2010, 52 (1-2) : 76 - 76
  • [2] Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
    Pozios, Ioannis
    Seel, Nina N.
    Hering, Nina A.
    Hartmann, Lisa
    Liu, Verena
    Camaj, Peter
    Mueller, Mario H.
    Lee, Lucas D.
    Bruns, Christiane J.
    Kreis, Martin E.
    Seeliger, Hendrik
    CELLULAR ONCOLOGY, 2021, 44 (01) : 167 - 177
  • [3] Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells
    Eric Ponce, Nicolas
    Antonio Carrera-Silva, Eugenio
    Vanina Pellegrini, Andrea
    Ines Cazorla, Silvia
    Luis Malchiodi, Emilio
    Paula Lima, Ana
    Gea, Susana
    Pilar Aoki, Maria
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (03): : 485 - 494
  • [4] Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
    Ioannis Pozios
    Nina N. Seel
    Nina A. Hering
    Lisa Hartmann
    Verena Liu
    Peter Camaj
    Mario H. Müller
    Lucas D. Lee
    Christiane J. Bruns
    Martin E. Kreis
    Hendrik Seeliger
    Cellular Oncology, 2021, 44 : 167 - 177
  • [5] Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by α-thrombin
    Gunaje, JJ
    Bhat, GJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) : 252 - 257
  • [6] Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
    Zanders, Lukas
    Kny, Melanie
    Hahn, Alexander
    Schmidt, Sibylle
    Wundersitz, Sebastian
    Todiras, Mihail
    Lahmann, Ines
    Bandyopadhyay, Arnab
    Wollersheim, Tobias
    Kaderali, Lars
    Luft, Friedrich C.
    Birchmeier, Carmen
    Weber-Carstens, Steffen
    Fielitz, Jens
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (01) : 713 - 727
  • [7] Ischemic preconditioning-induced expression of gp130 and STAT3 in astrocytes of the rat hippocampus
    Kim, SY
    Park, HJ
    Choi, JS
    Lee, JE
    Cha, JH
    Choi, YS
    Cho, KO
    Chun, MH
    Lee, MY
    MOLECULAR BRAIN RESEARCH, 2004, 129 (1-2): : 96 - 103
  • [8] Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy
    Selander, KS
    Li, L
    Watson, L
    Merrell, M
    Dahmen, H
    Heinrich, PC
    Müller-Newen, G
    Harris, KW
    CANCER RESEARCH, 2004, 64 (19) : 6924 - 6933
  • [9] IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors
    Rosell, Rafael
    Bertran-Alamillo, Jordi
    Molina, Miguel Angel
    Taron, Miquel
    FUTURE ONCOLOGY, 2009, 5 (03) : 305 - 308
  • [10] Defective glycosylation leads to impairment of gp130 expression and gp130-dependent STAT3 signaling in PGM3-deficient patients
    Barbouche, M. R.
    Ben-Khemis, L.
    Mekki, N.
    Benabdessalem, C.
    Yaakoubi, R.
    Ben-Mustapha, I.
    Ben-Ali, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1237 - 1238